Budesonide does not affect engraftment, clinical response after FMT in ulcerative colitis
Pretreatment with budesonide did not significantly influence engraftment among patients with ulcerative colitis who underwent fecal microbiota transplantation, with researchers reporting that clinical response appeared to be donor-dependent. “Several studies addressed the effects of FMT for UC, showing a response rate of around 36% for patients with various treatment regimens,”